Bio-Decontamination Market – By Product and Service (Equipment, Services, Consumables), Agent Type (Hydrogen Peroxide, Chlorine Dioxide), Type (Chamber Decontamination, Room Decontamination), End-user (Pharmaceutical, Life Science, Hospitals) – Global Forecast 2024 – 2032

Bio-Decontamination Market Size

Bio-Decontamination Market size was valued at around USD 229.5 million in 2023 and is anticipated to register a CAGR of 8.5% between 2024 and 2032. Bio-decontamination refers to the process of eliminating or reducing the presence of harmful microorganisms, such as bacteria, viruses, fungi, and spores from surfaces, equipment, or environments.
 

This procedure is essential in various industries, including healthcare, pharmaceuticals, biotechnology, and food processing companies to prevent the spread of infectious diseases and ensure product safety. Bio-decontamination methods commonly involve the use of chemical agents, such as disinfectants or sterilant, as well as physical methods such as heat or radiation, to achieve effective microbial elimination or reduction. The increasing prevalence of hospital acquired infections (HAIs) is a significant driver for the market.
 

For instance, according to data from the World Health Organization (WHO) in 2023, the rate of HAIs was 25% in developing countries, while in developed countries, it ranges from 5% to 15%. Thus, bio-decontaminations play a crucial role in mitigating the spread of infections and ensuring the safety of patients and healthcare workers. Furthermore, market growth is attributed to multiple factors, including the increasing number of surgical procedures, rising growth in pharmaceutical and biotechnology industry, and the escalating trend of outsourcing bio-decontamination services to third-party providers.
 

Bio-Decontamination Market Trends

The rapid expansion of the pharmaceutical and biotechnology industry has spurred a parallel growth trajectory in the demand for stringent bio-decontamination measures. As pharmaceutical and biotechnology companies strive for innovation and quality in their research, development, and manufacturing processes, the need to maintain clean and contamination-free environments becomes paramount.
 

• Pharmaceutical and biotechnology products are often highly sensitive and susceptible to contamination. Even trace amounts of contaminants can compromise product quality, efficacy, and safety. This is particularly critical in the production of sterile drugs, biologics, vaccines, and medical devices, where the risk of microbial contamination must be minimized to prevent adverse effects on patients.
   
• Further, these sectors are heavily regulated by stringent quality and safety standards imposed by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Compliance with these regulations requires meticulous attention to cleanliness, sterility, and contamination control throughout the manufacturing process.
   
• Moreover, the growth of the pharmaceutical and biotechnology industry has created a pressing need for effective bio-decontamination solutions to safeguard product quality, regulatory compliance, and patient safety.
   

Bio-Decontamination Market Analysis

Based on product and service, the bio-decontamination market is bifurcated into equipment, services, and consumables. The equipment segment held the market size of USD 145.6 million in 2023.
 

• Specialized bio-decontamination equipment is designed to deliver effective and efficient decontamination of surfaces, equipment, and environments. These systems often employ advanced technologies such as vaporized hydrogen peroxide (VHP), ozone, ultraviolet (UV) light, or dry heat to achieve rapid and thorough decontamination.
   
• For instance, in September 2021, STERIS introduced advanced integrated vaporized hydrogen peroxide (VHP) bio decontamination systems tailored for customers aiming to achieve significant bioburden reduction in good manufacturing practices (GMP) within the pharmaceutical, medical device, and research settings.
   
• Moreover, modern bio-decontamination equipment prioritizes safety for both operators and the environment. These systems are engineered with built-in safety features to prevent exposure to hazardous chemicals or radiation during operation.
   
• Thus, bio-decontamination equipment is highly versatile and adaptable, catering to diverse settings such as pharmaceutical cleanrooms, hospital operating rooms, laboratories, and food processing plants, thereby propelling the growth of the market.
   

Based on agent type, the bio-decontamination market is segmented into hydrogen peroxide, chlorine dioxide, peracetic acid, and nitrogen dioxide. The hydrogen peroxide segment is expected to reach a market size of USD 203.4 million by 2032.
 

• Hydrogen peroxide exhibits broad-spectrum antimicrobial activity, capable of effectively eliminating a wide range of microorganisms, including bacteria, viruses, fungi, and spores. This makes it suitable for use in diverse applications where comprehensive decontamination is required.
   
• Further, it acts quickly to kill microorganisms upon contact, leading to rapid decontamination of surfaces, equipment, and environments. This swift action helps to minimize downtime and ensures a prompt return to normal operations following decontamination procedures.
   
• Thus, hydrogen peroxide is considered safe for use in bio-decontamination processes, as it decomposes into water and oxygen without leaving any harmful residues or by-products, thereby driving the growth of the market.
   

Based on type, the bio-decontamination market is segmented into chamber decontamination and room decontamination. The chamber decontamination segment held a market size of USD 134.6 million in 2023.
 

• Chamber decontamination systems are designed to treat entire enclosed spaces, ensuring comprehensive coverage of all surfaces and hard-to-reach areas within the chamber. This ensures thorough decontamination of the entire environment, minimizing the risk of microbial contamination.
   
• Further, these systems utilize mechanisms such as aerosols, vaporization, or gaseous distribution to achieve uniform distribution of decontaminating agents throughout the enclosed space.
   
• Thus, chamber decontamination systems offer efficient and time-saving solutions for large-scale decontamination tasks. Compared to manual cleaning and disinfection methods, which can be labor-intensive and time-consuming, chamber decontamination allows for simultaneous treatment of multiple surfaces and areas within the chamber, reducing overall downtime and labor costs, thereby escalating the segmental growth of the market.
   

Based on end-user, the bio-decontamination market is segmented into pharmaceutical and medical device manufacturing companies, life sciences and biotechnology research organizations, and hospitals and healthcare facilities. The pharmaceutical and medical device manufacturing companies’ segment is estimated to reach USD 212.4 million by 2032.
 

• Pharmaceutical and medical device manufacturing companies are subject to strict regulatory requirements imposed by agencies like the FDA (Food and Drug Administration) or EMA (European Medicines Agency). Effective bio-decontamination processes are essential for compliance with good manufacturing practices (GMP) and other regulatory standards.
   
• Further, they often invest in cutting-edge technologies and equipment for manufacturing and quality control purposes. This includes state-of-the-art bio-decontamination systems such as hydrogen peroxide vapor generators, UV-C disinfection devices, and ozone sterilizers which can efficiently eliminate biological contaminants, thereby augmenting the segment growth of the market.
   

North America bio-decontamination market accounted for USD 93 million revenue in 2023 and is predicted to witness substantial market growth.
 

• The significant market share is correlated to the rising demand for surgical procedures, the continuous growth of the pharmaceutical and biotechnology sectors, and the increasing trend of outsourcing bio-decontamination services to third-party providers.
   
• North America invests significantly in research and development, leading to continuous advancements in bio-decontamination technologies and methodologies. This fosters innovation and drives improvements in decontamination effectiveness and efficiency.   
    
• Further, the region boasts a robust healthcare infrastructure with well-equipped hospitals, research facilities, and pharmaceutical manufacturing plants.
   

Bio-Decontamination Market Share

The bio-decontamination industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. Players compete through innovative product offerings, strategic partnerships, and expansion into emerging markets. Additionally, stringent regulations and standards in healthcare and pharmaceutical industries further intensify competition. The development and launch of novel advanced devices based on different technologies is among a key market strategy.
 

Bio-Decontamination Market Companies

Some of the eminent market participants operating in the bio-decontamination industry include:

• AM Instruments Srl
• Ecolab Inc.
• Fedegari Autoclavi SpA
• Howorth Air Technology Limited
• JCE Biotechnology
• Noxilizer, Inc.
• STERIS plc
• Tecomak.
• TOMI Environmental Solutions, Inc.
• Vaisala         
   

Bio-Decontamination Industry News:

• In July 2022, Ecolab's Bioquell HPV-AQ 35% hydrogen peroxide disinfectant had received approval from the European Chemicals Agency (ECHA) Biocidal Products Committee (BPC) for BPR EU (Union) Authorization. This approval had consolidated the company's position in the European market, enabling it to offer a trusted and effective disinfection solution to customers.
   
• In December 2022, TOMI Environmental Solutions, Inc. launched the new SteraMist products, notably the Select Plus, amalgamating the surface select and environment systems. Operating at 24 volts, it has enhanced hydrogen peroxide conversion to hydroxyl radicals, reducing H2O2 PPM levels and accelerating turnaround times. This launch enriched TOMI's portfolio and provided customers with enhanced disinfection capabilities.
   

Bio-Decontamination market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product and Service

• Equipment   
• Services       
• Consumables

Market, By Agent Type

• Hydrogen peroxide  
• Chlorine dioxide      
• Peracetic acid
• Nitrogen dioxide     

Market, By Type

• Chamber decontamination           
• Room decontamination

Market, By End-user

• Pharmaceutical and medical device manufacturing companies                     
• Life sciences and biotechnology research organizations                              
• Hospitals and healthcare facilities

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa